Icelandic Salmon AS (ICE:ISLAX)

Market Cap	35.77B
Revenue (ttm)	14.08B
Net Income (ttm)	-441.83M
Shares Out	n/a
EPS (ttm)	-14.27
PE Ratio	n/a
Forward PE	45.95
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,500
Average Volume	672
Open	1,170.00
Previous Close	n/a
Day's Range	1,170.00 - 1,170.00
52-Week Range	1,170.00 - 1,600.00
Beta	-0.05
RSI	29.71
Earnings Date	Aug 21, 2025

About Orchard Therapeutics

Icelandic Salmon AS, together with its subsidiaries, engages in production, processing, and sale of salmon and salmon-based products in Europe, North America, and Asia. It is involved in the salmon farming activities. The company was formerly known as Arnarlax AS and changed its name to Icelandic Salmon AS in October 2020. Icelandic Salmon AS was founded in 2001 and is headquartered in Kverva, Norway. Icelandic Salmon AS operates as a subsidiary of SalMar ASA.

• Industry: Farm Products
• Sector: Consumer Staples
• Founded: 2001
• Employees: 158
• Stock Exchange: Nasdaq Iceland
• Ticker Symbol: ISLAX